Activest Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Activest Wealth Management's BMRN Position: Q3 2026 in Review
Activest Wealth Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 166 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #581.
Activest Wealth Management first reported a position in BMRN in Q3 2022 and has held it in 6 quarters since. The position peaked at $181K in Q3 2022. 565 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Activest Wealth Management held 166 shares of BioMarin Pharmaceuticals worth $10K as of Q3 2026.
- Activest Wealth Management left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #581 holding.
- Activest Wealth Management first reported a position in BioMarin Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
- Activest Wealth Management's BioMarin Pharmaceuticals position peaked at $181K in Q3 2022.
- 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.